Literature DB >> 7979548

Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID mice.

W H Boehncke1, W Sterry, A Hainzl, W Scheffold, R Kaufmann.   

Abstract

Preliminary observations in a xenogeneic SCID mouse transplantation model indicated that murine epidermis overgrows human dermis from psoriatic skin but not that form normal skin. To investigate the effect of peripheral blood mononuclear cells on the differentiation of murine keratinocytes, we transplanted involved and uninvolved full-thickness skin from patients with psoriasis onto SCID mice and followed this with repeated subcutaneous injections of cells suspended in patient serum. After 6 weeks grafts were analysed morphologically and immunohistochemically. The epidermis in grafts from clinically uninvolved skin appeared normal. The persistence of a psoriasiform epidermis was noted in all grafts from affected sites despite a lack of lymphocytic infiltration. Staining for human and mouse MHC class I antigens revealed the murine origin of keratinocytes forming the psoriasiform epidermis, while the human dermis was retained. Our observations indicate that the defect underlying the pathogenesis of psoriasis is most likely located in the dermal rather than the epidermal compartment. This xenogeneic transplantation model may be useful for future studies of the pathogenesis and treatment of psoriasis.

Entities:  

Mesh:

Year:  1994        PMID: 7979548     DOI: 10.1007/BF00402223

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  18 in total

1.  Transplantation of Psoriatic Skin onto Nude Mice.

Authors:  J E Fraki; R A Briggaman; G S Lazarus
Journal:  J Invest Dermatol       Date:  1983-06       Impact factor: 8.551

2.  Multiple very late antigen (VLA) heterodimers on platelets. Evidence for distinct VLA-2, VLA-5 (fibronectin receptor), and VLA-6 structures.

Authors:  M E Hemler; C Crouse; Y Takada; A Sonnenberg
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

Review 3.  The pathomechanisms of psoriasis; the skin immune system and cyclosporin.

Authors:  J D Bos
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

4.  Normal and psoriatic human skin grafts on "nude" mice: morphological and immunochemical studies.

Authors:  M Haftek; J P Ortonne; M J Staquet; J Viac; J Thivolet
Journal:  J Invest Dermatol       Date:  1981-01       Impact factor: 8.551

5.  Monoclonal antibodies to mouse major histocompatibility complex antigens.

Authors:  K Ozato; N M Mayer; D H Sachs
Journal:  Transplantation       Date:  1982-09       Impact factor: 4.939

6.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

Authors:  F Sanchez-Madrid; A M Krensky; C F Ware; E Robbins; J L Strominger; S J Burakoff; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Biochemical characterization of VLA-1 and VLA-2. Cell surface heterodimers on activated T cells.

Authors:  M E Hemler; J G Jacobson; J L Strominger
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

Review 8.  The SCID mouse mutant: definition, characterization, and potential uses.

Authors:  M J Bosma; A M Carroll
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

9.  Integrin VLA-3: ultrastructural localization at cell-cell contact sites of human cell cultures.

Authors:  R Kaufmann; D Frösch; C Westphal; L Weber; C E Klein
Journal:  J Cell Biol       Date:  1989-10       Impact factor: 10.539

10.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.

Authors:  Z Werb; P M Tremble; O Behrendtsen; E Crowley; C H Damsky
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  9 in total

1.  Dermal injection of immunocytes induces psoriasis.

Authors:  T Wrone-Smith; B J Nickoloff
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 2.  Proteasome inhibition: a new anti-inflammatory strategy.

Authors:  Peter J Elliott; Thomas Matthias Zollner; Wolf-Henning Boehncke
Journal:  J Mol Med (Berl)       Date:  2003-03-26       Impact factor: 4.599

3.  Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions.

Authors:  John R Zibert; Katrin Wallbrecht; Margarete Schön; Lluis M Mir; Grete K Jacobsen; Veronique Trochon-Joseph; Céline Bouquet; Louise S Villadsen; Ruggero Cadossi; Lone Skov; Michael P Schön
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

Review 4.  [Psoriasis SCID-mouse model].

Authors:  J Pfeffer; R Kaufmann; W-H Boehncke
Journal:  Hautarzt       Date:  2006-07       Impact factor: 0.751

5.  Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model.

Authors:  Thomas M Zollner; Maurizio Podda; Christine Pien; Peter J Elliott; Roland Kaufmann; Wolf-Henning Boehncke
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

6.  Genetic background of psoriasis.

Authors:  Hani A Alshobaili; Muhammad Shahzad; Abdullah Al-Marshood; Alsayed Khalil; Ahmad Settin; Issam Barrimah
Journal:  Int J Health Sci (Qassim)       Date:  2010-01

7.  Proliferation and interferon-gamma receptor expression in psoriatic and healthy keratinocytes are influenced by interactions between keratinocytes and fibroblasts in a skin equivalent model.

Authors:  J Fransson; A Emilson; A Scheynius; H Hammar
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

8.  Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective.

Authors:  Pascale Zwicky; Susanne Unger; Burkhard Becher
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

Review 9.  Experimental Pharmacological Management of Psoriasis.

Authors:  Elena Campione; Terenzio Cosio; Monia Di Prete; Caterina Lanna; Annunziata Dattola; Luca Bianchi
Journal:  J Exp Pharmacol       Date:  2021-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.